ESPE Abstracts (2014) 82 NP2.1

ESPE2014 New Perspectives Regenerative Endocrinology (2 abstracts)

Regenerative Medicine for β Cell Replacement

R Scharfmann


Paris, France


Pancreatic β cells develop from endodermal pancreatic progenitors that first proliferate and next differentiate into functional insulin-producing cells. This developmental process is complex, each step being controlled by yet unknown signals. Theoretically, the development of a functional β cell mass can be enhanced by: i) activating the proliferation of pancreatic progenitors; ii) activating their differentiation into β cells; iii) activating the proliferation of β cells themselves.

During the past years, we first developed bioassays based on rodent models to search for signals that control specific steps of β cell development. With such bioassays, we screened and characterized a number of signals that regulate pancreatic progenitor cell proliferation and differentiation. We also developed models of human pancreatic development, to transfer to human, data generated in rodent models. Such models were instrumental for the development of functional human β cell of lines first and second generations. Such an approach, that aims at better dissecting signals regulating functional β cell mass in rodent and human will be presented.

Volume 82

53rd Annual ESPE (ESPE 2014)

Dublin, Ireland
18 Sept 2014 - 20 Sept 2014

European Society for Paediatric Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches

My recently viewed abstracts